Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-04
1999-03-02
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546199, A61K 31445, C07D40104
Patent
active
058771875
ABSTRACT:
New benzimidazole derivatives of formula: ##STR1## in which R.sub.1 is H or a short chain hydrocarbon group such as methyl, hyl, isopropyl, cyclopropyl, vinyl, etc., and R.sub.2 is a group selected from among the following: CH.sub.2 OH, COOH, COOR.sub.3 and 4,4-dimethyl-2-oxazolinyl, R.sub.3 being a short chain alkyl group such as methyl, ethyl, etc., are described.
A description is also made of the preparation of these compounds, which have a high H.sub.1 antihistaminic and antiallergic activity and are devoid of effects on the central nervous and cardiovascular systems.
REFERENCES:
Orjales et al, "Synthesis and structure-activity, etc" CA 124:8747, 1995.
Bordell Maravillas
Orjales Aurelio
Rubio Victor
Fabrica Espanola de Productos Quimicos y Farmaceuticos S.A. (FAE
Morris Patricia L.
LandOfFree
Benzimidazole derivatives with antihistaminic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives with antihistaminic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives with antihistaminic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423178